IGUB19086 / Jounce EMERGE Trial / Adrienne Victor
Basic Study Information
Purpose:Location: University of Rochester
JTX-2011-201 is a Phase 2, open label clinical study of vopratelimab (JTX-2011) and
ipilimumab in adult subjects with non-small cell lung cancer (NSCLC) or urothelial
cancer to evaluate safety and efficacy.
Lead Researcher (Principal Investigator)
Study Contact InformationStudy Coordinator: Amber Johnson
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search